Experimental and clinical study of the effects of pancuronium bromide, a neuromuscular blocking agent.
D000759:Adjuvants, Anesthesia; D000293:Adolescent; D000328:Adult; D000368:Aged; D000731:Androstanes / Q000627:therapeutic use*; D000818:Animals; D001965:Bromides; D004285:Dogs; D004357:Drug Synergism; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use*; D010197:Pancuronium / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D010880:Piperidines; D012131:Respiratory Insufficiency / Q000139:chemically induced; D013390:Succinylcholine / Q000494:pharmacology; D013831:Thiamine / Q000494:pharmacology
D000759:Adjuvants, Anesthesia; D000731:Androstanes; D001965:Bromides; D003473:Neuromuscular Nondepolarizing Agents; D010880:Piperidines; D009388:Neostigmine; D013390:Succinylcholine; D010197:Pancuronium; D013831:Thiamine